Related Experiment Video
Updated: Aug 17, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease
Z Layrisse1, M T Fernandez, S Montagnani
1Instituto Venezolano de Investigaciones Científicas, Centro de Medicina Experimental, Laboratorio de Fisiopatología, Caracas, Venezuela. zlayriss@medicina.ivic.ve
Insights
The HLA-C*03 gene may increase the risk of developing Chagas disease cardiomyopathy in Venezuelan patients. This contrasts with findings in Chilean patients, suggesting geographical variations in genetic susceptibility to Trypanosoma cruzi infection complications.
Area of Science:
- Immunogenetics
- Infectious Diseases
- Cardiology
Background:
- Chagas disease, caused by Trypanosoma cruzi infection, affects approximately one-third of chronically infected individuals with cardiomyopathy.
- Previous research indicated a role for Human Leukocyte Antigen (HLA) class I and class II genes in Chagas disease susceptibility and resistance.
- The specific genetic factors influencing cardiomyopathy development in T. cruzi-infected individuals remain incompletely understood.
Purpose of the Study:
- To investigate the association between specific HLA class I alleles and the susceptibility to cardiomyopathy in Venezuelan patients with chronic Trypanosoma cruzi infection.
- To identify HLA alleles that may confer risk or protection against the cardiac complications of Chagas disease.
Main Methods:
- Low and intermediate resolution DNA typing of HLA class I alleles was performed on 113 serologically positive individuals.
- Utilized a polymerase chain reaction-sequence-specific oligonucleotide probe method and Innogenetics LiPA kits for HLA typing.
- Compared allele frequencies between patients with and without cardiomyopathy, applying statistical corrections for multiple comparisons.
Main Results:
- Several HLA alleles (A*11, A*31, B*15, B*35, B*45, B*49, B*51, C*03) were more frequent in patients with cardiac damage.
- Only the HLA-C*03 allele remained statistically significant (OR = 5.8, p(c) = 0.03) after correcting for multiple comparisons.
- HLA-C*03 showed linkage disequilibrium with B*40 and B*15; these haplotypes were increased in cardiopathic patients but not significantly.
Conclusions:
- The HLA-C*03 allele may be associated with increased susceptibility to cardiomyopathy in Venezuelan T. cruzi-seropositive individuals.
- These findings contrast with a previously reported protective effect of the HLA B40 Cw3 haplotype in Chilean Chagas disease patients.
- Further research is necessary to validate the role of HLA-C*03 in the pathogenesis of Chagas disease cardiomyopathy.
Abstract:
Previous studies have shown the effect of class 1 as detected by serology or class 2 HLA genes by oligotyping upon susceptibility or resistance to the cardiomyopathy that develops in approximately one third of the Trypanosoma cruzi chronically infected patients. Low and intermediate resolution DNA typing of class 1 alleles was performed in a sample of 113 serologically positive individuals with and without cardiomyopathy. A polymerase chain reaction-sequence-specific oligonucleotide probe method using primers and probes from the British Society of Histocompatibility and Immunogenetics as modified for the VII Latin American Histocompatibility Workshop by D. Middleton, and LiPA kits from Innogenetics were used. Several alleles (A(*)11, A(*)31, B(*)15, B(*)35, B(*)45, B(*)49, B(*)51, and C(*)03) showed increased frequencies among patients with cardiac damage versus the asymptomatic group, but only the last one remained significant after correction of the p value (OR = 5.8, p(c) = 0.03). HLA-C(*)03 showed linkage disequilibrium with B(*)40 and B(*)15 and although both haplotypes were increased in cardiopathic patients compared with asymptomatic individuals, the difference is not significant. These results suggest that the HLA-C*03 allele could confer susceptibility to the development of cardiomyopathy among Venezuelan T. cruzi seropositive individuals and contrast with the protective effect conferred by the HLA B40 Cw3 haplotype among Chilean chagasic patients. Further studies will be needed to confirm the role of this allele on the cardiomyopathy of Chagas disease.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Hepatitis
American Trypanosomiasis

